JNJ's Combo Therapy Shows Strong Phase III Efficacy in Prostate Cancer

• click to rate

  Posted by Two Blokes Jun 4 - Filed in Stock - 8 views
  
  Johnson & Johnson's niraparib combo significantly delays prostate cancer progression in HRR-altered patients with strong phase III data.